Pharmacological approaches to the treatment of excessive drinking and alcohol dependence

References

• Thomas M, Walker A, Wilmot A, Bennett N (Eds.) Living in Britain: Results from the 1996 General Household Survey. 179–197 HMSO, London, UK (1998).
   Google Scholar
• Grant B. Prevalence and correlates of alcohol use and DSM IV alcohol dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. j Stud. Akohol58, 464–773 (1997).
   PubMedGoogle Scholar
• Robins LN, Helzer JE, Przybeck TR, Regier DA. Alcohol disorders in the community: a report from the epidemiologic catchment area. In: Alcoholism: Origins and Outcome. Rose RM, Barrett JE (Eds.), 15–29. Raven Press, New York, USA (1988).
   Google Scholar
• Meltzer H, Gill B, Petticrew M, Hinds K Economic Activity and Sodal Functioning of Adults with BychMtric Disorders. Report 3 London, HMSO. OPCS Surveys of Psychiatric Morbidity in Great Britain (1995).
   Google Scholar
• Harwood H, Fountain D, Livermore G. The economic costs of alcohol and drug abuse in the United States, 1992. Department of Health and Human Services, NIH Publication No. 98–4327, Rockville, USA (1998).
   Google Scholar
• Drummond DC, Moncrieff J. The continuing search for the 'elixir of temperance'. Addiction 92,961–964 (1997).
   Google Scholar
• Smith R. Journals fail to adhere to guidelines on conflicts of interest. BE Med. 323,651A (2001).
   Google Scholar
• Moncrieff J, Drummond DC. New drug treatments for alcohol problems: a critical appraisal. Addiction 92,939–947 (1997).
   PubMed Web of Science ®Google Scholar
• •This paper provides a useful critical review of a wide range of drug treatments for alcohol problems and has been highly cited.
   Google Scholar
• Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT Pharmacological treatment of alcohol dependence: a review of the evidence. JAIVIA 281,1318–1325 (1999).
   PubMed Web of Science ®Google Scholar
• ••This is an excellent review of the literature ofpharmacotherapy for alcohol dependence.
   Google Scholar
• Kranzler HR. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcoholism 35,537–547 (2001).
   Google Scholar
• ••This is an excellent critical review of theliterature with a description of opportunities for future research.
   Google Scholar
• Moncrieff J, Drummond DC. The quality of alcohol treatment research: an examination of influential controlled trials and development of a quality rating system. Addiction 93,811–823 (1998).
   PubMed Web of Science ®Google Scholar
• Nutt D. 'Tis a wonder it works at all' Addiction 92(8), 958–959 (1997).
   Google Scholar
• Kranzler HR, Babor TF. Is the medication bottle half full or half empty. Addiction 92(8), 951–953 (1997).
   Google Scholar
• Chick J. Pitfalls and possibilities in evaluating pharmacotherapies for alcohol dependence. Addiction 92(8), 953–956 (1997).
   Google Scholar
• Soyka M. Pharmacological trials in alcoholics-some comments on methodological problems. Addiction 92(8), 956–957 (1997).
   Google Scholar
• Littleton J. Is there a baby in the bathwater? Addiction 92 (8), 960–961 (1997) .
   Google Scholar
• Drummond DC, Litten RZ, Lowman C, Hunt WA. Craving research: future directions. Addiction 95 (Suppl. 2), S247—S255 (2000).
   Google Scholar
• Hughes JC, Cook CC. The efficacy of disulfiram: a review of outcome studies. Addiction 92,381–395 (1997).
   PubMed Web of Science ®Google Scholar
• ••This is a comprehensive review of theliterature on disulfiram in alcohol dependence.
   Google Scholar
• Chick J. The efficacy of treatments in reducing alcohol consumption: a meta-analysis. Subst. Use Misuse 31,1081 (1996).
   PubMedGoogle Scholar
• Chick J. Treatment of alcoholic violent offenders: ethics and efficacy. Alcohol Alcoholism 33,20–25 (1998).
   PubMedGoogle Scholar
• O'Farrell TJ, Pals-Stewart W Family- involved alcoholism treatment: an update. Recent Dev. Alcohol15, 329–356 (2001).
   PubMedGoogle Scholar
• cyFarrell TJ, Allen JP, Litten RZ. Disulfiram (antabuse) contracts in treatment of alcoholism. MDA Res. Monogr 150, 65–91 (1995).
   Google Scholar
• Fuller RIK, Branchey L, Brightwell DR et al Disulfiram treatment of alcoholism: a Veterans Administration co-operative study. JA/V/4 256,1449–1455 (1986).
   Google Scholar
• Carroll KM, Nich C, Ball SA, McCance E, Frankforter TL, Rounsaville BJ. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction 95,1335–1349 (2000).
   PubMed Web of Science ®Google Scholar
• Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcoholism 36,2–10 (2001).
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. CD001867 (2000).
   Google Scholar
• •This is an excellent systematic review of opioid antagonists in alcohol dependence from the Cochrane collaboration.
   Google Scholar
• Chick J, Anton R, Checinski K et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcoholism 35,587–593 (2000).
   PubMed Web of Science ®Google Scholar
• O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor PG. Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. I Clin. PTchophatmacol 20,69–76 (2000).
   PubMed Web of Science ®Google Scholar
• Rohsenow DJ, Colby SM, Monti PM et al Predictors of compliance with naltrexone among alcoholics. Alcohol Clin. Exp. Res. 24,1542–1549 (2000).
   PubMed Web of Science ®Google Scholar
• Maxwell S, Shinderman MS. Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. I Addict. Dis. 19,61–69 (2000).
   PubMed Web of Science ®Google Scholar
• Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch. Gen. Psychiatry 56,719–724 (1999).
   Google Scholar
• Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR. Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug- Alcohol Depend. 49,9–16 (1997).
   PubMed Web of Science ®Google Scholar
• Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. Abnorm. Psycho" 109(4), 738–742 (2000).
   Google Scholar
• Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral therapy for the treatment of out-patient alcoholics: results of a placebo-controlled trial. Am. PTchiatry 156,1758–1764 (1999).
   PubMed Web of Science ®Google Scholar
• Davidson D, Palfai T, Bird C, Swift R. Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin. Exp. Res. 23,195–203 (1999).
   PubMed Web of Science ®Google Scholar
• Anton RE Neurobehavioural basis for the pharmacotherapy of alcoholism: currentand future directions. Alcohol Alcoholism 31 (Suppl. 1), 43–53 (1996).
   Google Scholar
• •This is an excellent review of the scientific basis for pharrnacotherapy in alcoholism.
   Google Scholar
• Paille FM, Guelfi JD, Perkins AC, Royer RJ, Stem L, Parot P Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcoholism 30,239–247 (1995).
   PubMed Web of Science ®Google Scholar
• Chick J, Howlett H, Morgan MY, Ritson B. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcoholism 35,176–187 (2000).
   PubMed Web of Science ®Google Scholar
• Annemans L, Vanoverbeke N, Tecco J, D'Hooghe D. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. Eur. Addict. Res. 6,71–78 (2000).
   Google Scholar
• Palmer AJ, Neeser K, Weiss C, Brandt A, Comte S, Fox M. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Akohol Akoholism 35,478–492 (2000).
   PubMed Web of Science ®Google Scholar
• Foster RH, McClellan KJ. Acamprosate: pharmacoeconomic implications of therapy. PharmacoEconomics 16, 743–755 (1999).
   PubMed Web of Science ®Google Scholar
• Lesch OM, Riegler A, Gutierrez K et al The European acamprosate trials: conclusions for research and therapy. Blamed. Sci. 8, 89–95 (2001).
   Google Scholar
• Rubio G, Jimenez-Arriero MA, Ponce G, Palomo T Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Akohol Alcoholism 36, 419–425 (2001).
   PubMed Web of Science ®Google Scholar
• COMBINE Research Group. (2002, In press).
   Google Scholar
• Miller N, Fine J. Epidemiology of comorbidity in addiction psychiatry. In: The Principles and Practice of Addictions in Bychiatry Miller NS (Ed.) W.B. Saunders, London, UK (1997).
   Google Scholar
• Kranzler HR, Del Boca FK, Rounsaville BJ. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a post-treatment natural history study. J. Stud. Alcohol57, 619–626 (1997).
   Google Scholar
• Schneider U, Altmann A, Baumann M et al Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany. A/coho/A/coho/ism 36, 219–223 (2001).
   Google Scholar
• Brower KJ, Aldrich MS, Robinson EA, Zucker RA, Greden JE Insomnia, self-medication and relapse to alcoholism. Am. PTchtry158, 399–404 (2001).
   PubMed Web of Science ®Google Scholar
• Wetterling T Medical treatment of psychiatric comorbidity in alcoholics.Bychiatr Proc. 28, 257–261 (2001).
   Google Scholar
• Modesto-Lowe V, Kranzler HR Diagnosis and treatment of alcohol-dependent patients with comorbid psychiatric disorders. Alcohol Res. Health 23, 144–149 (1999).
   PubMedGoogle Scholar
• Drake RE, Xie H, McHugo GJ, Green AI. The effects of clozapine on alcohol and drug use disorders in patients with schizophrenia. Schizophr Bull 26, 441–449 (2000).
   PubMed Web of Science ®Google Scholar
• Keaney F, Strang J, Gossop M et al. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide. Alcohol Alcoholism 36, 426–430 (2001).
   PubMedGoogle Scholar
• Gual A, Lehert P Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol Alcoholism 36, 413–418 (2001).
   PubMed Web of Science ®Google Scholar
• Drummond, DC. Naltrexone in the treatment of alcohol dependence: whatclinicians need to know. Addiction 96, 1857–1859 (2001).
   PubMed Web of Science ®Google Scholar
• Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the Alcohol Timeline Follow-Back when administered by telephone and by computer. Drug 'Alcohol Depend. 42, 49–54 (1996).
   PubMed Web of Science ®Google Scholar
• Lawford BR, Young RM, Rowell JA et al. Bromocriptine in the treatment of alcoholics with the D2 receptor Al allele. Nat. Med. 1, 337–341 (1995).
   Google Scholar
• Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin. Exp. Res. 24(7), 1041–1049 (2000).
   Google Scholar
• Johnson BA, Roache JD, Javors MA et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomised controlled trial. JA/V/A 284, 963–971 (2001).
   Google Scholar
• Feeney GF, Connor JP, Young RM, Tucker J, Czajkowski E Adherence with naltrexone prescription advice in hospital out-patient alcohol rehabilitation programme. J. Gun. Pharm. Ther. 26, 73–79 (2001).
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Modesto-Lowe V, Nuwayser ES. Sustained-release naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin. Exp. Res. 22, 1074–1079 (1998).
   PubMed Web of Science ®Google Scholar
• Swift RM, Duncan D, Nirenberg T, Femino J. Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism. j Addict. Dis. 17, 35–47 (1998).
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. Motivational Intervieff4ng Preparing People to Change Addictive Behaviour Guilford, NY, USA (1991).
   Google Scholar
• Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker. Alcohol Clin. Exp. Res. 25, 847–849 (2001).
   PubMed Web of Science ®Google Scholar
• O'Malley SS, Jaffe AJ, Chang G et al. Six- month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch. Gen. Bychiatry 53, 217–224 (1996).
   Google Scholar
• Smith DE, Heckemeyer CM, Kraft PP, Mason DA. Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM: a pilot study. Diabetes Care 20, 52–54 (1997).
   PubMed Web of Science ®Google Scholar
• Lingford-Hughes AR, Acton PD, Gacinovic S et al Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br. PTchiatry 173, 116–122 (1998).
   PubMed Web of Science ®Google Scholar
• Nutt D. Alcohol and the brain: pharmacological insights for psychiatrists. Br. PTchiatry175, 114–119 (1999).
   Google Scholar
• Weinstein A, Feldtkeller B, Malizia A, Wilson S, Bailey J, Nutt DJ. Integrating the cognitive and physiological aspects of craving. J Bychopharmacol 12, 31–38 (1998).
   PubMed Web of Science ®Google Scholar
• Drummond DC, Lowman C, Litten RZ, Hunt WA (Eds.) Research perspectives on alcohol craving. Addiction 95 Supp1.2, S45—S255 (2000).
   Google Scholar
• ••This is a comprehensive review of the nature of alcohol craving from basic to human research which is essential in understanding the application of drug therapies in alcohol dependence.
   Google Scholar
• Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Shadel WG. The measurement of drug craving. Addiction 95 (Suppl. 2), S189—S210 (2001).
   Google Scholar
• Drummond DC. What does cue reactivity have to offer clinical research? Addiction 95(Suppl. 2), S129—S144 (2000).
   Google Scholar
• Drummond DC, Tiffany S, Glautier SP, Remington B. Cue exposure in understanding and treating addictive behaviours. In: Addictive Behaviour: Cue exposure Theory and Practice. Drummond DC, Tiffany S, Glautier SP, Remington B (Eds.) 1–17 John Wiley & Sons, Chichester, UK (1995).
   Google Scholar